Glucagon is a hormone produced by α cells ... Dr. Kaestner added, "This research uncovers a critical mechanism that helps maintain blood sugar balance, moving us closer to understanding the ...

Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on developing treatments for liver disease and obesity, has been garnering attention ...

Scientists may have identified a way to naturally regulate blood sugar levels and sugar cravings in a similar fashion to ...

Get Instant Summarized Text (Gist) Glucagon-like peptide 1 receptor agonists (GLP1RA), used for type 2 diabetes and obesity, are linked to behavioral side effects. An analysis of genetic variants ...

GLP1RA mimic the GLP-1 hormone in the body that helps control insulin and blood glucose levels and promotes feelings of satiety. GLP-1 binds to GLP1R on cells in the brain and pancreas.

While older anti-obesity drugs may lead to less weight loss than semaglutide and tirzepatide, they remain useful tools in ...

Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents—have ...

Amgen's Q4 2024 earnings show a 19% revenue increase year-on-year, with non-GAAP EPS up 13% in Q4 and 6% for the full year.

Coya Therapeutics expands its pipeline, advancing COYA 303 with a dual immunomodulatory mechanism for inflammatory ... combination of COYA 301 and a glucagon-like-peptide-1 receptor agonist ...

Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...

Use of a sodium-glucose cotransporter 2, or SGLT2, inhibitor combined with calorie restriction resulted in greater rates of type 2 diabetes remission compared with calorie restriction alone, according ...

One hormone found in platypus venom, glucagon-like peptide-1 (GLP-1), plays a role in increasing insulin and regulating blood sugar levels, which could potentially help with new diabetes treatments.